Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-03 Sale |
2025-03-05 6:55 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
1,000 | $48.09 | $48,090 | 111,674 (Direct) |
View |
| 2025-01-27 Sale |
2025-01-29 8:43 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
5,000 | $57.03 | $285,150 | 112,674 (Direct) |
View |
| 2024-12-16 Sale |
2024-12-18 9:03 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
1,000 | $29.13 | $29,130 | 86,358 (Direct) |
View |
| 2024-12-10 Sale |
2024-12-12 8:29 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
925 | $30.79 | $28,481 | 17,858 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 6:04 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
569 | $22.64 | $12,883 | 18,562 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-03 Exercise |
2025-03-05 6:55 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
1,000 | $19.87 | 111,674 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 6:55 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
1,000 | $0 | 111,674 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-29 8:43 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
4,000 | $19.87 | 112,674 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-29 8:43 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
4,000 | $0 | 112,674 (Direct) |
View |
| 2024-12-31 Option Award |
2025-01-29 8:43 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
234 | $19.69 | 112,674 (Direct) |
View |
| 2024-12-16 Option Award |
2024-12-18 9:03 pm |
N/A 2034-12-15 |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
69,500 | $0 | 86,358 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 6:56 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
221 | $19.94 | 18,783 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-12 4:35 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Lamy Patrick See Remarks |
102,134 | $0 | 102,134 (Direct) |
View |
| 2023-01-10 Option Award |
2023-01-11 7:51 pm |
N/A 2033-01-09 |
Akero Therapeutics Inc. | AKRO | Lamy Patrick See Remarks |
100,000 | $0 | 100,000 (Direct) |
View |